André Wyss
Chief Executive Officer bei IMPLENIA AG
Vermögen: 5 Mio $ am 31.03.2024
Profil
André Wyss currently works at Implenia AG, as Chief Executive Officer from 2018, Economiesuisse, as Director, Ina Invest Holding Ltd., as Non-Executive Director from 2020, Ina Invest AG, as Member-Supervisory Board, and E.
Merck KG, as Member-Shareholders Board from 2024.
Mr. Wyss also formerly worked at Novartis Corp., as President, Novartis AG, as President-Novartis Operations from 2016 to 2018, and Novartis Pharmaceuticals Corp., as President & Head-Pharma North America from 2010 to 2014.
Mr. Wyss received his undergraduate degree in 1995 from School of Economics & Business Administration.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMPLENIA AG
0,55% | 31.12.2022 | 102 448 ( 0,55% ) | 4 Mio $ | 31.03.2024 |
INA INVEST LTD.
0,36% | 31.12.2023 | 60 430 ( 0,36% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von André Wyss
| Unternehmen | Position | Beginn |
|---|---|---|
| IMPLENIA AG | Chief Executive Officer | 01.10.2018 |
| INA INVEST AG | Director/Board Member | 01.01.2020 |
Economiesuisse
 Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Director/Board Member | - |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Corporate Officer/Principal | 01.01.2024 |
Ehemalige bekannte Positionen von André Wyss
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Chief Operating Officer | 01.04.2018 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | President | 01.04.2014 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | President | 01.04.2014 |
Ina Invest AG
 Ina Invest AG Real Estate Investment TrustsFinance Ina Invest AG engages in the development of real estate properties. Its property portfolio includes hotels, offices, and residential homes. The company is headquartered in Zurich, Switzerland. | Director/Board Member | - |
Ausbildung von André Wyss
| School of Economics & Business Administration | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| IMPLENIA AG | Industrial Services |
| INA INVEST AG | Finance |
| Private Unternehmen | 5 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Economiesuisse
Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Health Services |
Ina Invest AG
Ina Invest AG Real Estate Investment TrustsFinance Ina Invest AG engages in the development of real estate properties. Its property portfolio includes hotels, offices, and residential homes. The company is headquartered in Zurich, Switzerland. | Finance |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Health Technology |
